Normal lab panels mean nothing if clinical outcomes never improve. Board-certified cardiologist Dr. Jack Wolfson walked away from a conventional hospital practice to expose why standard treatment algorithms fail cardiac patients.
Treating isolated biomarkers like LDL and APOB with lifelong statin prescriptions often builds false safety without stopping disease progression. True cardiovascular health requires targeting upstream drivers: chronic inflammation, environmental mold toxicity, and circadian biology.
For clinicians and patients facing stubborn cardiovascular diagnoses, this conversation offers a clear framework to challenge standard protocols and address genuine root causes. Subscribe to the channel and send this episode to a colleague who questions standard care. Which cardiac biomarker gets too much emphasis in your clinic?
Member discussion: